Last checked at 6 Feb 2024 12:08
HARGREAVES LANSDOWN PLC (HL): CHAIR SUCCESSION
06 February 2024
Further to its announcement on 29 November 2023 and following regulatory approval of Alison Platt, the Board of HL is pleased to announce her appointment to role of Chair of the Board and as a Non-Executive Director of HL with effect from today, Tuesday 06 February 2024.
Other than the directorships disclosed above, there are no matters required by paragraphs LR 9.6.13R (1) to (6) of the listing rules to be disclosed.
For further information please contact: | |
Hargreaves Lansdown | Brunswick |
James Found, Investor Relations 07970 066 634 | Nick Cosgrove +44(0)207 404 5959 |
Danny Cox, Media Relations 07989 672 071 | |
BIOGRAPHY
Alison Platt
Alison has extensive leadership experience across both private and listed companies in the healthcare, financial services, retail and property, and regulated sectors. She currently holds Chair positions at Dechra Pharmaceuticals, a FTSE100 specialist veterinary products business, and insurance company Ageas UK. She has also been a Non-Executive Director of Tesco Plc since 2016.
Alison was CEO of Countrywide from 2014 - 2018 and prior to that she held several senior roles at BUPA, including as Managing Director of its International Development Markets business. She was previously a Non-executive director of the Foreign and Commonwealth Office, a member of Hampton-Alexander review steering group advising on diversity and inclusion and Chair of Opportunity Now.